Ranbaxy sues US FDA; Stock Slips

Shares of the company were seen trading lower by 4% at Rs 603 on BSE at 3.00 pm IST. Stock touched an intra-day low of Rs 596.
Earlier this month, the company had received communication from the US FDA wherein FDA has determined that Ranbaxy's ANDAs of concern did not have any data integrity issues. Ranbaxy was disappointed with this and was actively evaluating all available options to preserve its rights.
Also, Ranbaxy will be moved out of NSE's CNX Nifty Junior index. The changes are due to merger with Sun Pharmaceuticals Industries Ltd.
GoodReturns.in
More From GoodReturns

Indane, HP & Bharat Gas Cylinder Booking Rules: OTP Mandatory After LPG Refilling Gap Increased to 25-45 Days

Crash in Gold Rate in India by Rs 71,400 in Single Day; Will Gold Price Today Fall Below Rs 1.50 Lakh? Outlook

Gold & Silver Rates Today Live: MCX Gold Crashes By Rs 5,645, Silver Falls By Rs 16,540; 24K, 22K, 18K Gold

1:1 Bonus, 1:5 Split, 39 Dividends: Hindustan Zinc Share Rally 3% As Silver Rates Jump: Buy This Vedanta Stock

1:5 Split Soon? Vedanta Ltd To Consider 3rd Interim Dividend On March 23, Share Jumps; Record Date & Buy Call

Gold Rates & Silver Rates Today Live: MCX Gold & Silver Price Gives Up Some Early Gains; 24K, 22K, 18K Gold

Bengaluru Power Cut Today: Key Areas To Face 7-Hour Power Outage for BESCOM Maintenance On March 15| Full List

Gold Rates In India Crash Continues Today, 24K, 22K, 18K Gold Prices On Mar-16; Gold Rate Falls By Rs 41,400

Emirates, Etihad, Air India Express Cancel Dubai, Abu Dhabi, Dammam Flights on 16-17 March; Check Status Today

DigiLocker PVR Storage: How Indian Citizens Can Digitally Save Passport Verification Records?

Massive Crash in Gold Rate in India! 24K Plunges Nearly Rs 59,000 in Four Sessions; Will Slide Continue Today?



Click it and Unblock the Notifications